Prokidney (PROK) Retained Earnings (2021 - 2026)
Prokidney (PROK) reported Retained Earnings of -$53000.0 for Q1 2026, up 100.0% year-over-year from -$26500.6 in Q1 2025, and down 194.64% quarter-over-quarter from $56000.0 in Q4 2025.
Prokidney (PROK) Retained Earnings (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Retained Earnings data on file, last reported at -$53000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$53000.0, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$53000.0 (up 100.0% YoY), and the FY2025 annual result was $56000.0, up 100.0% from the prior year.
- Retained Earnings retreated to -$53000.0 in Q1 2026 per PROK's latest filing, from $56000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $321000.0 in Q3 2024 and troughed at -$1.4 billion in Q2 2023.
- A 5-year average of -$493.2 million and a median of -$12.4 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 600.0% in 2025 and fell as far as 2767134.09% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$1.1 billion in 2022, then soared by 100.01% to $130000.0 in 2023, then sank by 923830.0% to -$1.2 billion in 2024, then surged by 100.0% to $56000.0 in 2025, then tumbled by 194.64% to -$53000.0 in 2026.
- Business Quant data shows PROK's Retained Earnings at -$53000.0 in Q1 2026, $56000.0 in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | -1.25 Bn |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | -1.22 Bn |
| Dec 31, 2024 | -1.20 Bn |
| Sep 30, 2024 | 321,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -44,000.00 |
| Dec 31, 2023 | 130,000.00 |
| Sep 30, 2023 | -1.13 Bn |
| Jun 30, 2023 | -1.35 Bn |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | -1.10 Bn |
| Sep 30, 2022 | -1.10 Bn |
| Jun 30, 2022 | -15.00 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Dec 31, 2021 | -161.51 Mn |
| Sep 30, 2021 | -6.32 Mn |
| Jun 30, 2021 | -5,325.00 |